Suppr超能文献

机器人与常规保乳乳头切除术治疗乳腺癌的术后并发症和手术结果:荟萃分析。

Postoperative complications and surgical outcomes of robotic versus conventional nipple-sparing mastectomy in breast cancer: meta-analysis.

机构信息

School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.

General Surgery, Aberdeen Royal Infirmary, Aberdeen, UK.

出版信息

Br J Surg. 2024 Jan 3;111(1). doi: 10.1093/bjs/znad336.

Abstract

BACKGROUND

Breast cancer is the most common cancer worldwide, with remarkable advances in early diagnosis, systemic treatments, and surgical techniques. Robotic nipple-sparing mastectomy has been trialled; however, the complication rates, surgical outcomes, and oncological safety of this approach remain obscure.

METHODS

A systematic search of the literature was conducted from conception until September 2022. Studies examining complications and operative variables where robotic nipple-sparing mastectomy was compared with conventional nipple-sparing mastectomy were included. Primary study outcomes were complications (Clavien-Dindo grade III complications, skin or nipple necrosis, seroma, haematoma, infection, implant loss, and wound dehiscence) and oncological safety (recurrence and positive margins). The secondary outcomes included operative variables, length of stay, cost-effectiveness, learning curve, and aesthetic outcome.

RESULTS

A total of seven studies of overall fair quality, involving 1674 patients, were included in the systematic review and meta-analysis. Grade 3 complications were reduced in robotic nipple-sparing mastectomy without statistical significance (OR 0.60 (95 per cent c.i. 0.35 to 1.05)). Nipple necrosis was significantly reduced in robotic nipple-sparing mastectomy (OR 0.54 (95 per cent c.i. 0.30 to 0.96); P = 0.03; I2 = 15 per cent). Operating time (mean difference +58.81 min (95 per cent c.i. +28.19 to +89.44 min); P = 0.0002) and length of stay (mean difference +1.23 days (95 per cent c.i. +0.64 to +1.81 days); P < 0.0001) were significantly increased in robotic nipple-sparing mastectomy, whereas the opposite was true for blood loss (mean difference -53.18 ml (95 per cent c.i. -71.78 to -34.58 ml); P < 0.0001).

CONCLUSION

Whilst still in its infancy, robotic breast surgery may become a viable option in breast surgery. Nonetheless, the oncological safety of this approach requires robust assessment.

摘要

背景

乳腺癌是全球最常见的癌症,在早期诊断、系统治疗和手术技术方面取得了显著进展。机器人乳头保留乳房切除术已经进行了试验;然而,这种方法的并发症发生率、手术结果和肿瘤安全性仍不清楚。

方法

从构思到 2022 年 9 月进行了系统的文献检索。纳入了比较机器人乳头保留乳房切除术与传统乳头保留乳房切除术的并发症和手术变量的研究。主要研究结果是并发症(Clavien-Dindo 分级 III 级并发症、皮肤或乳头坏死、血清肿、血肿、感染、植入物丢失和伤口裂开)和肿瘤安全性(复发和阳性切缘)。次要结果包括手术变量、住院时间、成本效益、学习曲线和美容效果。

结果

共纳入 7 项总体质量中等的研究,涉及 1674 例患者,进行了系统评价和荟萃分析。机器人乳头保留乳房切除术的 3 级并发症减少,但无统计学意义(OR 0.60(95%可信区间 0.35 至 1.05))。机器人乳头保留乳房切除术的乳头坏死显著减少(OR 0.54(95%可信区间 0.30 至 0.96);P = 0.03;I2 = 15%)。手术时间(平均差异+58.81 分钟(95%可信区间+28.19 至+89.44 分钟);P = 0.0002)和住院时间(平均差异+1.23 天(95%可信区间+0.64 至+1.81 天);P<0.0001)明显增加,而机器人乳头保留乳房切除术的出血量减少(平均差异-53.18 毫升(95%可信区间-71.78 至-34.58 毫升);P<0.0001)。

结论

虽然机器人乳房手术仍处于起步阶段,但它可能成为乳房手术的一种可行选择。然而,这种方法的肿瘤安全性需要进行严格评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/778f/10769157/b25636d99552/znad336f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验